Scienture Holdings, Inc.
SCNX
$0.61
$0.00-0.13%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 809.24% | -- | -- | -58.74% | -83.46% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 809.24% | -- | -- | -58.74% | -83.46% |
| Cost of Revenue | -74.75% | -- | -- | -79.27% | -82.70% |
| Gross Profit | 14,633.33% | -- | -- | 102.46% | -90.15% |
| SG&A Expenses | 112.06% | 188.59% | -45.43% | 51.18% | 180.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 38.98% | 240.59% | -34.80% | 79.14% | 208.73% |
| Operating Income | -24.68% | -244.85% | 34.98% | -87.02% | -359.21% |
| Income Before Tax | -13.31% | -313.65% | 53.81% | -45.18% | -3,513.62% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.31% | -313.65% | 53.81% | -34.61% | -3,513.62% |
| Earnings from Discontinued Operations | -- | -- | -- | 94.56% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.31% | -266.46% | -114.42% | 38.60% | 9.69% |
| EBIT | -24.68% | -244.85% | 34.98% | -87.02% | -359.21% |
| EBITDA | -24.71% | -244.93% | 34.99% | -195.16% | -360.77% |
| EPS Basic | 85.81% | 63.56% | -101.59% | 93.40% | 70.66% |
| Normalized Basic EPS | 85.25% | 61.22% | 94.78% | 80.05% | -1,073.95% |
| EPS Diluted | 85.81% | 63.32% | -101.61% | 93.38% | 70.66% |
| Normalized Diluted EPS | 85.25% | 61.22% | 94.78% | 80.05% | -1,073.95% |
| Average Basic Shares Outstanding | 698.62% | 905.57% | 809.12% | 830.10% | 207.81% |
| Average Diluted Shares Outstanding | 698.62% | 905.57% | 809.12% | 830.10% | 207.81% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |